# Senior Scientist II, Mass Spectrometry, Platform Biology & Bioanalysis — CytomX Therapeutics

- Location: Emeryville, CA
- Posted pay: $175k–$200k/yr
- Posted: Nov 9, 2026
- Status: open (checked Nov 21, 2026)
- Apply (employer's site): https://jobs.jobvite.com/cytomx/job/ofT4Afww
- Employer record: https://visajobs.io/company/cytomx-therapeutics.md

## Sponsorship history
- Tier: Employer history only
- With this exact title: 0

## Description
Headquarters Location: Emeryville, CA
Candidate Location: Hybrid
Travel Required: 5%
Reports To: VP, Platform Biology & Bioanalysis
Department: Platform Biology & Bioanalysis
Position Type: Full-time, Exempt
About CytomX Therapeutics:
CytomX Therapeutics, Inc. is committed to changing the treatment of cancer with our novel PROBODY® therapeutic platform. Our commitment to transforming lives with safer, more effective therapies is driven by our curiosity and passion for innovation and our belief that by acting with integrity in an honest, respectful, ethical manner, we have the power to change lives. Our workplace embodies collaboration, open communication, celebrating our successes, and holding each other to the highest possible standards. CytomX’s robust and differentiated pipeline comprises therapeutic candidates across multiple treatment modalities including antibody-drug conjugates (“ADCs”), T-cell engagers, and immune modulators such as cytokines. CytomX’s clinical-stage pipeline includes CX-2051 and CX-801. Learn more at  www.cytomX.com .
Who You Are and What You’ll Do:
You are passionate about life sciences and making a difference to cancer patients, their families, and healthcare providers. You will serve as the in-house mass spectrometry expert supporting Platform Biology, Bioanalysis, and ADC research programs. The role will be responsible for designing and executing studies that inform molecule characterization, metabolism, catabolism, linker-payloads, biomarkers, and mechanism of action. The position will partner broadly across Research and Development to address complex analytical challenges and translate MS data into actionable program decisions.
Job Responsibilities:
Serve as the subject matter expert for mass spectrometry-based characterization of biologics, antibody-drug conjugates (ADCs), linker-payloads, and related biomolecules across discovery and development programs.
Design, develop, and implement LC-MS/MS and high-resolution mass spectrometry methods to support molecule characterization, linker-payload stability, catabolism, payload release, and mechanism-of-action studies.
Lead characterization of ADC attributes including drug-to-antibody ratio (DAR), conjugation heterogeneity, linker stability, payload-related species, and degradation products.
Apply mass spectrometry and proteomics approaches to investigate protease biology, protease substrate specificity, and protease-mediated processing relevant to CytomX's Probody® and ADC platforms.
Collaborate with cross-functional teams to generate analytical data that informs candidate selection, optimization, and development decisions.
Develop innovative mass spectrometry approaches for characterization of proteins, peptides, biomarkers, and complex biological matrices.
Provide scientific leadership in the interpretation of mass spectrometry data and communicate findings to multidisciplinary teams.
Oversee and scientifically direct external CRO activities requiring specialized mass spectrometry expertise.
Author technical reports, study summaries, scientific publications, and presentations.
Mentor junior scientists and contribute to building scientific excellence across the organization.
Stay current with emerging advancements in mass spectrometry, proteomics, and analytical technologies and evaluate opportunities for implementation at CytomX.
Independently define and manage budget and other resources for own team and projects overseen.
Minimum Qualifications:
Ph.D. in Analytical Chemistry, Biochemistry, Pharmaceutical Sciences, Molecular Biology, or a related discipline with 4-5+ years of relevant industry experience. Extensive hands-on experience with LC-MS/MS and mass spectrometry platforms (e.g., Orbitrap and triple quadrupole instruments) in a biotechnology, pharmaceutical, or CRO environment.
Demonstrated expertise in mass spectrometry-based characterization of proteins, monoclonal antibodies, antibody-drug conjugates (ADCs), and/or other complex biologics.
Experience developing, optimizing, and troubleshooting mass spectrometry workflows and interpreting complex datasets to support research and development programs.
Preferred Qualifications:
Experience developing and applying novel mass spectrometry-based approaches to address complex biological, biochemical, and mechanistic questions.
Experience characterizing antibody-drug conjugates (ADCs), including drug-to-antibody ratio (DAR), conjugation heterogeneity, linker-payload stability, payload release, and catabolite characterization.
Strong understanding of protein chemistry, bioconjugation, post-translational modifications, and analytical characterization of biologics.
Knowledge of protease biology and enzyme–substrate interactions, including cleavage-site specificity and the kinetics of proteolytic processing; experience applying it to cleavable linkers, prodrugs, or other protease-activated molecules is a plus.
Proven ability to analyze, interpret, and communicate complex datasets to multidisciplinary scientific teams.
Experience with advanced analytical and bioanalytical technologies, including capillary electrophoresis (CE), capillary isoelectric focusing (cIEF), ELISA/Ligand Binding Assays, CE-MS, and mass spectrometry-based approaches for characterization of biologics and ADCs.
Experience developing novel analytical approaches to address complex biological and biochemical questions.
Excellent communication and collaboration skills, with a demonstrated ability to work effectively in cross-functional teams.
Experience managing external CROs and scientific collaborations.
Demonstrated project leadership and mentoring experience in a biotechnology environment.
Excellent written and verbal communication skills, with the ability to effectively present scientific findings to diverse audiences.
Demonstrated ability to work independently while successfully collaborating within cross-functional teams.
Records of scientific achievements demonstrated through publicatio

> History, not a promise: past H-1B filings do not mean an employer will sponsor you or a given role. Data: U.S. DOL OFLC LCA disclosure (FY2024–FY2026 for role counts, certified LCAs) and the USCIS H-1B Employer Data Hub. Not legal advice. Methodology: https://visajobs.io/methodology
